Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- University of Pittsburgh
- Study ID
- NCT00258570
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The purposes of this study are: * to determine if there are specific genetic traits that might explain why patients have developed pulmonary fibrosis; * to determine if specific genetic traits account for differing patterns of inflammation and scar tissue that has formed in the patient's lungs.
Key Dates
- Start date
- Jan 31, 2003
- Status verified
- Sep 2025
- Primary completion
- Jul 31, 2035
- Completion
- Jul 31, 2035
Study Design
- Enrollment
- 2,000 participants (estimated)
Primary Outcome Measure
Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF) [ Time Frame: Sample collection will occur up to 5 years based on the current rate of sample collection. ]
Central Contacts
- Michelle F MacPherson, MAT412-647-4537
- Michelle Meyers, BSN412-692-2149
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | Yingze Zhang, PhD (SUB_INVESTIGATOR) Rajiv Dhir, MD (SUB_INVESTIGATOR) Prabir Ray, PhD (SUB_INVESTIGATOR) Luis A Ortiz, M.D. (SUB_INVESTIGATOR) Daniel J. Kass, M.D. (SUB_INVESTIGATOR) Kristen Veraldi, M.D. (SUB_INVESTIGATOR) Kevin F. Gibson, M.D. (PRINCIPAL_INVESTIGATOR) Michelle F. MacPherson, BS, MAT (SUB_INVESTIGATOR) Michelle Meyers, BSN, RN (SUB_INVESTIGATOR) Eleanor Valenzi, MD (SUB_INVESTIGATOR) Daniel Sullivan, MD (SUB_INVESTIGATOR) Xiaoping Chen, MS (SUB_INVESTIGATOR) Seyed Mehdi Nouraie, PhD (SUB_INVESTIGATOR) Morgan Carnahan, BS (SUB_INVESTIGATOR) Timothy Corcoran, PhD (SUB_INVESTIGATOR) Xiaoyun Li, MD (SUB_INVESTIGATOR) |
Find similar trials in Pittsburgh, PA
By research site
Related Studies
- Global Utilization And Registry Database for Improved preservAtion of doNor LUNGsEnrolling By Invitation · Paragonix Technologies · Phoenix, Arizona
- A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary FibrosisPHASE2 · Recruiting · Avalyn Pharma Inc. · Birmingham, Alabama
- Role of Genetic Factors in the Development of Lung DiseaseRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Explanted Lung Tissues With Pulmonary FibrosisRecruiting · University of Chicago · Chicago, Illinois